Med BioGene Taps JRG for Strategic Advice to Help Launch Cancer Dx | GenomeWeb
NEW YORK (GenomeWeb News) — Med BioGene said today that it has hired JRG Ventures for strategic business advice as it moves to commercialize a new genomic-based diagnostic test for lymphoma.
 
JRG will help the company define its partnering and commercialization strategy as it prepares to roll out its clinical laboratory LymphExpress Dx test.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.